H. Lennernas et Cg. Regardh, DOSE-DEPENDENT INTESTINAL-ABSORPTION AND SIGNIFICANT INTESTINAL EXCRETION (EXSORPTION) OF THE BETA-BLOCKER PAFENOLOL IN THE RAT, Pharmaceutical research, 10(5), 1993, pp. 727-731
The elimination of [H-3]pafenolol and metabolites was investigated in
fasted and fed rats. Separate groups received intravenous doses (0.3 a
nd 3.0 mumol/kg) and oral doses (1 and 25 mumol/kg). After iv administ
ration of pafenolol, the excretion of unchanged drug into urine and fe
ces was about 50 and 25-30% of the given dose, respectively. The predo
minating mechanism for the excretion of pafenolol into feces was intes
tinal excretion (exsorption) directly from blood into gut lumen, since
only about 3% of a given iv dose was recovered as pafenolol in the bi
le. When the oral dose was raised from 1 to 25 mumol/kg, the mean (+/-
SD) bioavailability, calculated from urine data, increased from 14 +/-
9 to 30 +/- 11% (P < 0.05) in the starved rats and from 14 +/- 3 to 1
6 +/- 3% in the fed animals. In parallel, the fraction absorbed from t
he gut (f(a)) increased from 19 +/- 9 to 31 +/- 10% in the starved rat
s and from 16 +/- 4 to 19 +/- 5% in the fed animals, respectively. Thi
s indicates that the low bioavailability is due primarily to poor inte
stinal uptake.